Vincent J. Angotti - Sep 11, 2023 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role
Chief Executive Officer, Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Stock symbol
ACRX
Transactions as of
Sep 11, 2023
Transactions value $
$7,950
Form type
4
Date filed
9/11/2023, 07:13 PM
Previous filing
Mar 6, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Purchase $7.95K +10K +12.22% $0.80 91.8K Sep 11, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes non-reportable acquisitions of 7,969 and 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023 and August 31, 2023, respectively.